Start | Grid View | Browse by Day OR Group/Topical | Author Index | Keyword Index | Personal Scheduler

Crystallization of Pharmaceutical and Biological Molecules 2: In Honor of the Late Dr. Jeff Wei of Eli Lilly

Thursday, November 11, 2010: 8:30 AM
Grand Ballroom D (Salt Palace Convention Center)

Description:
Additional session to cope with high rate of submissions.


Sponsor:
Pharmaceuticals
Co-Sponsor(s):
Crystallization and Evaporation (02B)


Chair:
Derek Griffin
Email: griffindw@lilly.com

Co-Chair:
Ryan C. Snyder
Email: ryan.snyder@bucknell.edu



8:30 AM
Introductory Remarks


8:35 AM
(141a) A Streamlined Approach to Avoiding Oiling in Crystallization Processes of Api's and Intermediates
Mourad Hamedi, Micaela Caramellino, Kelvin Yong and Xiaoyong Fu


8:55 AM
(141b) Crystallization Development of a Pharmaceutical API through Implementation of Real-Time Supersaturation Feedback Control
James Vernille, Jose Tabora, Amanda Rogers, Jacob Albrecht, Richard D. Braatz and Mitsuko Fujiwara


9:15 AM
(141c) Designing a Reactive Crystallization Process for An Agglomerating API
Jennifer Kuehne-Willmore, Jeffrey Vicenzi, Sarah O'Keeffe and Douglas Kjell


9:35 AM
(141d) Use of a Crystallization Modifier to Enhance Impurity Rejection in the Crystallization of a Pharmaceutical Intermediate
Ann M. Czyzewski, Shuang Chen, Su Yu, Ian Marsden, Chen Ding, Calvin Becker and James J. Napier


9:55 AM
(141e) Crystallization Tendency of Amorphous Pharmaceuticals Prepared by Rapid Solvent Evaporation: Classification, Comparison with Undercooled Melts and Interpretation in Terms of Physico-Chemical Drug Compound Characteristics
Bernard Van Eerdenbrugh, Jared Baird and Lynne Taylor


10:15 AM
(141f) Spiral Growth Model for Organic Crystals of Real Complexity: How to Account for Non-Isotropic Behavior
Zubin B. Kuvadia and Michael F. Doherty


10:35 AM
(141g) Population Balance Modeling of Morphology Distribution of Asymmetric Crystals
Meenesh R. Singh, Jayanta Chakraborty and Doraiswami Ramkrishna
See more of this Group/Topical: Food, Pharmaceutical & Bioengineering Division
<< Previous Session | Next Session >>